Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin
- PMID: 77050
Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin
Abstract
The major plasmin inhibitors namely alpha2-plasmin inhibitor and alpha2-macroglobulin were compared for their effects on lysis of fibrin clot. Plasmin fibrinolytic activity was immediately inhibited by alpha2-plasmin inhibitor, whereas alpha2-macroglobulin inhibited plasmin progressively. Urokinase(plasminogen activator)-induced clot lysis was inhibited efficiently by alpha2-plasmin inhibitor present in the clot. Inhibition of urokinase-induced clot lysis by alpha2-macroglobulin was weak and the molar concentration necessary for alpha2-macroglobulin to achieve the same degree of inhibition as that achieved with alpha2-plasmin inhibitor was about 10 times higher than that of alpha2-plasmin inhibitor. Binding of Lys-plasminogen to fibrin was inhibited by alpha2-plasmin inhibitor but not by alpha2-macroglobulin. Molar concentrations of alpha2-plasmin inhibitor which were effective in inhibiting the binding were 30 times less than that of 6-aminohexanoicacid. alpha2-Plasmin inhibitor was found to interact with Lys-plasminogen to form a weakly-bound complex which is dissociable in the presence of 6-aminohexanoic acid, suggesting that inhibition of binding of Lys-plasminogen to fibrin by alpha2-plasmin inhibitor may be due to interaction of alpha2-plasmin inhibitor with a specific site of the plasminogen molecule and that the site may be 6-aminohexanoic acid-binding site. It is suggested that alpha2-plasmin inhibitor is more reactive and efficient inhibitor of fibrinolysis than alpha 2-macroglobulin.
Similar articles
-
Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.J Lab Clin Med. 1984 Dec;104(6):962-76. J Lab Clin Med. 1984. PMID: 6239000
-
Effect of phenylglyoxal-modified alpha2-antiplasmin on urokinase-induced fibrinolysis.Thromb Haemost. 1998 Oct;80(4):637-44. Thromb Haemost. 1998. PMID: 9798984
-
The behavior of alpha2-plasmin inhibitor in fibrinolytic states.J Clin Invest. 1977 Aug;60(2):361-9. doi: 10.1172/JCI108784. J Clin Invest. 1977. PMID: 68962 Free PMC article.
-
[Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].Vopr Med Khim. 1984 Sep-Oct;30(5):13-22. Vopr Med Khim. 1984. PMID: 6084892 Review. Russian.
-
[Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].Rocz Akad Med Bialymst (1989). 1988-1989;33-34:53-66. Rocz Akad Med Bialymst (1989). 1988. PMID: 2979011 Review. Polish.
Cited by
-
Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin.J Clin Invest. 1982 Aug;70(2):412-23. doi: 10.1172/jci110631. J Clin Invest. 1982. PMID: 6178757 Free PMC article.
-
Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.J Clin Invest. 1980 Feb;65(2):290-7. doi: 10.1172/JCI109671. J Clin Invest. 1980. PMID: 6444305 Free PMC article.
-
Streptokinase, urokinase, and tissue plasminogen activator: pharmacokinetics, relative advantages, and methods for maximizing rates and consistency of lysis.Cardiovasc Intervent Radiol. 1986;9(5-6):236-44. doi: 10.1007/BF02577952. Cardiovasc Intervent Radiol. 1986. PMID: 3100038
-
Effects of Plasmin on von Willebrand Factor and Platelets: A Narrative Review.TH Open. 2018 Jun 7;2(2):e218-e228. doi: 10.1055/s-0038-1660505. eCollection 2018 Apr. TH Open. 2018. PMID: 31249945 Free PMC article. Review.
-
Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.J Clin Invest. 1982 Mar;69(3):536-42. doi: 10.1172/jci110479. J Clin Invest. 1982. PMID: 7199538 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources